Synergistic enhancement of PR(B)-mediated RU486 and R5020 agonist activities through cyclic adenosine 3',5'-monophosphate represents a delayed primary response

Molecular Endocrinology

Volumn 12, Issue 2, 1998, Pages 278-289

  Kahmann, Sabine ^a   Vaßen, Lothar ^a   Klein Hitpass, Ludger ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; MIFEPRISTONE; PROGESTERONE RECEPTOR; PROMEGESTONE; PROGESTERONE RECEPTOR B;

ANIMAL CELL; ARTICLE; DRUG MECHANISM; DRUG RECEPTOR BINDING; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROGESTERONE METABOLISM; TRANSACTIVATION; BIOSYNTHESIS; CELL FRACTIONATION; CHROMOSOME; DRUG POTENTIATION; FEMALE; GENETICS; HELA CELL; METABOLISM; MOUSE MAMMARY TUMOR ONCOVIRUS; PHYSIOLOGY; REPORTER GENE;

ANIMALIA;

CHROMOSOMES; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DRUG SYNERGISM; FEMALE; GENES, REPORTER; HELA CELLS; HUMANS; MAMMARY TUMOR VIRUS, MOUSE; MIFEPRISTONE; PROMEGESTONE; RECEPTORS, PROGESTERONE; SUBCELLULAR FRACTIONS;

EID: 0032216545     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.12.2.0067     Document Type: Article

References (48)

1. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
2. Steroid hormone receptors: Many actors in search of a plot
3. Steroid receptors and their associated proteins
4. Glucocorticoid and progesterone receptors bind to the same sites in two hormonally regulated promoters
5. A DNA sequence of 15 base pairs is sufficient to mediate both glucocorticoid and progesterone induction of gene expression
6. Nuclear receptor coactivators and corepressors
7. Interaction of steroid hormone receptors with the transcription initiation complex
8. The progesterone receptor stimulates cell-free transcription by enhancing the formation of a stable preinitiation complex
9. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B
10. The N-terminal region of the chicken progesterone receptor specifies target gene activation
11. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors
12. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function
13. The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells
14. A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of B-isoform
15. New T47D breast cancer cell lines for the independent study of progesterone A- and B-receptors: Only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP
16. Progesterone receptor A and B protein expression in human breast cancer
17. Two types of antiprogestines identified by their differential action in transcriptionally active extracts from T47D cells
18. Type II antagonists impair the DNA binding of steroid hormone receptors without affecting dimerization
19. In vivo evidence against the existence of antiprogestins disrupting receptor binding to DNA
20. Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor
21. Receptors bound to antiprogestin form abortive complexes with hormone response elements
22. Regulation of progesterone receptor activity in cell culture systems and cell-free transcription
23. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
24. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
25. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor
26. The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor
27. The coupling of multiple signal transduction pathways with steroid response mechanisms
28. Novel mechanism of antiprogestin action
29. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators
30. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor
31. Activation of the human androgen receptor through a protein kinase A signaling pathway
32. Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP
33. The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways
34. The two faces of a steroid antagonist: When an antagonist isn't
35. Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: Antiestrogen selectivity and promoter dependence
36. Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase A
37. New T47D breast cancer cell lines for the independent study of progesterone A- and B-receptors: Only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP
38. Role of phosphorylation on DNA binding and transcriptional functions of human progesterone receptors
39. Identification of two distinct regulatory regions adjacent to the human β-interferon gene
40. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies
41. Ten years after: Reclassification of steroid-responsive genes
42. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT
43. Luciferase reporter gene vectors for analysis of promoters and enhancers
44. Regulation of expression of mouse mammary tumor virus through sequences located in the hormone response element: Involvement of cell-cell contact and a negative regulatory factor
45. Both isoforms of the cAMP-dependent protein kinase catalytic subunit can activate transcription of the prolactin gene
46. Epitope tagging and protein surveillance
47. Ribonuclease protection assay